WO2001036400A1 - Verfahren zur herstellung von 2-chlor-5-chlormethyl-1,3-thiazol - Google Patents
Verfahren zur herstellung von 2-chlor-5-chlormethyl-1,3-thiazol Download PDFInfo
- Publication number
- WO2001036400A1 WO2001036400A1 PCT/EP2000/010318 EP0010318W WO0136400A1 WO 2001036400 A1 WO2001036400 A1 WO 2001036400A1 EP 0010318 W EP0010318 W EP 0010318W WO 0136400 A1 WO0136400 A1 WO 0136400A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compound
- chloro
- chloromethyl
- reaction
- Prior art date
Links
- 0 CCC(C1)(C2*C)N2C1C1[C@@]2(*CC2)CCC1 Chemical compound CCC(C1)(C2*C)N2C1C1[C@@]2(*CC2)CCC1 0.000 description 2
- KJJJFRXSKKUBAR-UHFFFAOYSA-N O=CC(CCl)N=C=S Chemical compound O=CC(CCl)N=C=S KJJJFRXSKKUBAR-UHFFFAOYSA-N 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
- C07C331/16—Isothiocyanates
- C07C331/18—Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms
- C07C331/20—Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Definitions
- the invention relates to processes for the preparation of 2-chloro-5-chloromethyl-1, 3-th ⁇ azol (CCT), and then used intermediate compounds
- EP 0 260 560 and EP 0 446 913 describe the preparation of CCT by reacting allyl isothiocyanate or allyl isothiocyanate substituted with a leaving group with a chlorinating agent and in EP 0 763 531 the reaction of 2-chloroallyl isothiocyanate with a chlorinating agent have disadvantages, since, for example, several by-products occur in the first variant, as a result of which the CCT produced is of low purity, and the starting material in the second variant is only available at high costs. Furthermore, a considerable excess of chlorinating agent must be used and it must be in large dilution.
- EP 0 794 180 describes the improvement as an improvement CCT from 1, 3-dichloropropene and a thiocyanate salt over 3-chloro-1- ⁇ soth ⁇ ocyanat-1-propene described
- the invention accordingly relates to a process for the preparation of 2-chloro-5-chloromethyl-1, 3-th ⁇ azol, which is characterized in that a compound of the formula
- X is OR, SR or NR 2 , where RH or a suitable protective group, Y is Cl and Z is O, with thiourea to give a compound of the formula implemented and then the amino group is replaced by a chlorine atom by means of a Sandmeyer reaction, whereupon 2-chloro-5-chloromethyl-1, 3-thiazole is obtained by chlorination and optionally ether cleavage or
- the starting compound for the preparation of CCT is a compound of the formula (I) in which X is Cl, -OR, -SR or NR 2 , where RH or a protective group is YH or Cl and Z Cl or O mean, wherein the compounds of formula (I) have at most one double bond between C * and C "or between C" and Z, with the proviso that the bond between C "and Z, when Z is O, a double bond and when Z is Cl, a single bond is in the formula (I), the radical RH or a protective group.
- a protective group all groups are suitable which are suitable for protecting the oxygen, sulfur or nitrogen radical. These are, among others, C 1 -C 6 alkyl groups such as methyl, ethyl, propyl, i-butyl, t-butyl, hexyl, or the phthahmide group
- X and Y are chlorine and Z are oxygen, so that 2,3-dichloropropane is used as the starting compound of the formula (I) 2,3-D ⁇ chlorpropanal is easily accessible, for example by chlorinating acrolein in dichloromethane
- the conversion of the aldehyde to CCT can be carried out according to the invention by variants a ⁇ or a 2 )
- the aldehyde can first be reacted with Na- or NH -Rhodan ⁇ d to the compound of formula (II).
- the rhodanide can be used both aquimolar and in excess or in deficit based on the aldehyde. However, the rhodanide is preferred The reaction is carried out in a suitable solvent.
- Suitable solvents are conventional organic solvents. These are, for example, carboxylic acids with 1 to 6 carbon atoms, such as in formic acid, acetic acid, propionic acid, etc., halogenated aliphatic and aromatic hydrocarbons, such as methylene chloride , T ⁇ chloromethane, t ⁇ chlorethylene, carbon tetrachloride, chlorobenzene, dichlorobenzene etc., alcohols such as methanol, ethanol, propanol, t-butanol, etc., ethers such as diethyl ether, dipropyl ether, dnsopropyl ether, dibutyl ether, t-butyl methyl ether, Ethylene glycol monomethyl ether, tetrahydrofuran, dioxane, etc., ketones, such as acetone, methyl ethyl ket on, methyl-i-butyl ketone, cyclohexanone
- phase transfer catalyst a phase transfer catalyst
- the preferred amount of added phase transfer catalyst amounts to thereby 0.1 -15 mol% of phase transfer catalyst are crown ethers, quatemare ammonium salts such as Tetramethylammoniumchlo ⁇ d, traethylammoniumchlo ⁇ d Te Tetrabutylammoniumchlo ⁇ d, Benzylt ⁇ methylammoniumchlo ⁇ d, as well as quaternary phosphonium salts
- Preferred solvents of variant ai) are C 3 -C 3 -carboxylic acids, nitriles, chlorinated aliphatic hydrocarbons and amides. Acetic acid, acetonitrile, dimethylformamide and a methylene chloride / crown ether mixture are particularly preferred
- the temperature is between 10 and 150 ° C, preferably between 15 and 130 ° C, particularly preferably between 20 and 80 ° C
- the compound of formula (II) is then by adding an acid / R ' OH or acid / orthoester mixture at temperatures of 10 to 100 ° C in the acetal of the formula
- Suitable acids are, for example, HCl or p-toluenesulfonic acid
- Suitable alcohol ROH are C t -Ce alcohols, such as methanol, ethanol, propanol
- Ethanol is preferably used
- Suitable orthoesters are, for example, alkyl orthoformate, such as methyl or ethyl orthoformate
- the aldehyde can also first be converted into the corresponding acetal. This transfer is carried out analogously to the above method.
- the acetal is then reacted analogously to the above method by reaction with Na- or NH 4 -Rhodan ⁇ d to the compound of formula (III)
- the compound of the formula (III) is then converted into 2-chloro-5-chloromethyl-1, 3-thiazole by suitable steps, such as rearrangement, cleavage of the alcohol or ether cleavage, reaction with a chlorinating agent, etc. It is also possible to convert the aldehyde of the formula (II) directly into 2-chloro-5-chloromethyl-1, 3-thiazole by suitable steps.
- the aldehyde of formula (I) is first mixed with thiourea to form a mixture of the compounds N - [[5- (2-aminothiazol) yl] methyl] thiourea and [5- (2-aminothiazol) yl] methylthioformamidin Formulas (IVa) and (IVb) implemented in the form of their hydrochloride salts. 0.8 to 2 equivalents of thiourea are preferably used.
- the reaction takes place in one of the suitable solvents listed under variant a ⁇ . Ketones such as methyl i-butyl ketone, acetone or alcohols such as methanol, ethanol, butanol are preferably used.
- the reaction temperature is between 15 ° C and the boiling point of the solvent used.
- the conversion to CCT is carried out by basic cleavage to give the corresponding thiol or amine, followed by Sandmeyer diazotization and optionally chlorination.
- Sandmeyer diazotization is carried out under the reaction conditions customary for this reaction, for example with inorganic or organic nitrites, preferably with sodium nitrite or t-butyl nitrite in HCl (for example aqueous HCl) or in mixtures of HCl and an organic polar solvent, such as acetonitrile, if appropriate Presence of a copper halide catalyst.
- Suitable chlorinating agents are those compounds which release chlorine under the reaction conditions. These are, for example, Cl 2 , sulfuryl chloride, PCI 5 , PCI 3 , POC, etc.
- reaction in the chlorination is carried out in a generally customary manner
- X is a radical -OR, -SR or NR 2 with R equal to H or a suitable protective group, Y Cl and Z oxygen
- the ether group is then optionally split and the corresponding residue is substituted by a chlorine atom.
- the cleavage and chlorination are also carried out analogously to a 2 )
- X means OR, SR or NR 2 with R equal to H or a suitable protective group
- Suitable solvents are again the solvents listed under variant a1). Amides, alcohols or nitriles are preferably used.
- the reaction is particularly preferably carried out in DMF, methanol or ethanol, or in acetonitrile
- the reaction temperature is between 0 ° C and the boiling point of the solvent used.
- radical X is then optionally cleaved by suitable known methods for deprotection, whereby the corresponding radical OH, SH or NH 2 is obtained.
- the cleavage takes place, for example, under acidic, basic or hydrogenolytic conditions.
- X, Y and Z represent a chlorine atom and the compound has no double bond.
- the starting compound is accordingly 1, 2,3-trichloropropane, which is reacted with thiourea to give the thiazolidine of the formula (VII).
- thiourea can be used in an equimolar amount, in a lower or an excess based on trichloropropane.
- Suitable solvents are the solvents listed under variant a ⁇ . The reaction temperatures are between 0 ° C and the boiling point of the solvent used.
- the thiazolidine is then dehydrogenated by adding customary aromatizing agents (customary dehydrating agents), such as sulfur, chloranil, DDQ, platinum oxide, etc., under the reaction conditions customary for dehydrogenation.
- customary aromatizing agents such as sulfur, chloranil, DDQ, platinum oxide, etc.
- X and Z represent a chlorine atom
- Y is H and the compound has a double bond between C * and C ".
- 1,3-dichloroprop-1-ene is used as the starting compound, which is mixed with a suitable oxidizing agent, such as a peroxy acid, an acid / H 2 O 2 mixture, inorganic or organic peroxides or hydroperoxides in 2-chloro-3-chloromethyl-ox ⁇ ran under conditions known from the literature
- Suitable solvents are preferably nitriles such as acetonitrile or chlorinated hydrocarbons such as chloroform, carbon tetrachloride, methylene chloride 1,2-dichloroethane or chlorobenzene
- Suitable peroxyacids are, for example, peracetic acid, m-chloro-perbenzoic acid, etc.
- Suitable solvents are the solvents listed under variant ai).
- Preferred solvents of variant e ⁇ are Alcohols, especially methanol, ethanol and t-butanol, ketones, especially acetone, nitriles, especially acetonitrile, ethers, especially tetrahydrofuran, dimethoxyethane, amides, especially N-methylpyrrolidone, water or mixtures with water, especially acetone / H 2 O- or acetone / H 2 O mixtures.
- the ether group in order to obtain CCT, the ether group must be split and chlorination carried out analogously to the variants already described and the ether cleavage and the Chlorination can take place before, after the diazotization or in some cases simultaneously with the diazotization. It is also possible to carry out the ether cleavage and the chlorination in one step.
- the oxirane or epoxide obtained is reacted analogously to variant c) with ammonium dithiocarbamate or ammonium thiocarbamate to give CCT, the cleavage of the radical X optionally being omitted analogously to variant e ⁇
- the isolation and processing of the CCT produced is carried out by customary methods, such as extraction, distillation, etc
- Example 1 Preparation of a mixture of N - [[5- (2-aminothiazol) yl] methyl] thiourea and [5- (2-aminothiazol) yl] methylthioformamidine
- reaction mixture was filtered and then extracted exhaustively with chloroform.
- organic phases were washed with sodium bicarbonate solution and water and freed from the solvent
- reaction mixture was filtered and then extracted exhaustively with chloroform.
- organic phases were washed with sodium hydrogen carbonate solution and water and freed from the solvent.
- the crude 2-amino-5-chloromethylthiazole was suspended in 10 ml of concentrated hydrochloric acid and 3.4 ml of acetonitrile and at -13 to -7 ° C. first with 1.98 g (20 mmol) of copper (I) chloride, then slowly with 2.89 g (28 mmol) tert. Butyl nitrite in 3.4 ml of acetonitrile was added and the mixture was stirred at room temperature for 2 hours.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE50002398T DE50002398D1 (de) | 1999-11-15 | 2000-10-20 | Verfahren zur herstellung von 2-chlor-5-chlormethyl-1,3-thiazol |
EP00967893A EP1230229B1 (de) | 1999-11-15 | 2000-10-20 | Verfahren zur herstellung von 2-chlor-5-chlormethyl-1,3-thiazol |
JP2001538889A JP2003523951A (ja) | 1999-11-15 | 2000-10-20 | 2−クロロ−5−クロロメチル−1,3−チアゾールの製造方法 |
AU77893/00A AU7789300A (en) | 1999-11-15 | 2000-10-20 | Method for producing 2-chloro-5-chloromethyl-1,3-thiazol |
US10/111,011 US6812348B1 (en) | 1999-11-15 | 2000-10-20 | Method for producing 2-chloro-5-chloromethyl-1,3-thiazol |
DK00967893T DK1230229T3 (da) | 1999-11-15 | 2000-10-20 | Fremgangsmåde til fremstilling af 2-chlor-5-chlormethyl-1,3-thiazol |
AT00967893T ATE241606T1 (de) | 1999-11-15 | 2000-10-20 | Verfahren zur herstellung von 2-chlor-5- chlormethyl-1,3-thiazol |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT191499A AT409760B (de) | 1999-11-15 | 1999-11-15 | Verfahren zur herstellung von 2-chlor-5-chlormethyl-1,3-thiazol |
ATA1914/99 | 1999-11-15 | ||
ATA46/2000 | 2000-01-14 | ||
AT462000 | 2000-01-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001036400A1 true WO2001036400A1 (de) | 2001-05-25 |
Family
ID=25597158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/010318 WO2001036400A1 (de) | 1999-11-15 | 2000-10-20 | Verfahren zur herstellung von 2-chlor-5-chlormethyl-1,3-thiazol |
Country Status (10)
Country | Link |
---|---|
US (1) | US6812348B1 (de) |
EP (1) | EP1230229B1 (de) |
JP (1) | JP2003523951A (de) |
AT (1) | ATE241606T1 (de) |
AU (1) | AU7789300A (de) |
DE (1) | DE50002398D1 (de) |
DK (1) | DK1230229T3 (de) |
ES (1) | ES2194783T3 (de) |
PT (1) | PT1230229E (de) |
WO (1) | WO2001036400A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE297385T1 (de) * | 2000-08-10 | 2005-06-15 | Bayer Cropscience Ag | Verfahren zur reinigung von 2-chlor-5- chlormethylthiazol |
JP4561068B2 (ja) * | 2003-09-04 | 2010-10-13 | 株式会社クレハ | 2−クロロ−1,3−チアゾール−5−メタノール誘導体、その製造法および農園芸用病害防除剤 |
CN114716356B (zh) * | 2022-03-10 | 2023-09-26 | 上海应用技术大学 | 一种铑催化合成异硫氰酸酯类化合物的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0446913A1 (de) * | 1990-03-16 | 1991-09-18 | Takeda Chemical Industries, Ltd. | Verfahren zur Herstellung von Chlorothiazolderivaten |
EP0763531A1 (de) * | 1995-09-14 | 1997-03-19 | Fine Organics Ltd. | Herstellung von substituierten Thiazolen |
EP0780384A2 (de) * | 1995-12-22 | 1997-06-25 | Bayer Ag | Verfahren zur Herstellung von 2-Chlor-5-chlormethylthiazol |
EP0794180A1 (de) * | 1996-02-21 | 1997-09-10 | Kuraray Co., Ltd. | Verfahren zur Herstellung von 2-Chloro-5-Chloromethyl-1,3-Thiazol |
-
2000
- 2000-10-20 US US10/111,011 patent/US6812348B1/en not_active Expired - Fee Related
- 2000-10-20 AT AT00967893T patent/ATE241606T1/de not_active IP Right Cessation
- 2000-10-20 DK DK00967893T patent/DK1230229T3/da active
- 2000-10-20 EP EP00967893A patent/EP1230229B1/de not_active Expired - Lifetime
- 2000-10-20 JP JP2001538889A patent/JP2003523951A/ja not_active Withdrawn
- 2000-10-20 DE DE50002398T patent/DE50002398D1/de not_active Withdrawn - After Issue
- 2000-10-20 WO PCT/EP2000/010318 patent/WO2001036400A1/de active IP Right Grant
- 2000-10-20 PT PT00967893T patent/PT1230229E/pt unknown
- 2000-10-20 ES ES00967893T patent/ES2194783T3/es not_active Expired - Lifetime
- 2000-10-20 AU AU77893/00A patent/AU7789300A/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0446913A1 (de) * | 1990-03-16 | 1991-09-18 | Takeda Chemical Industries, Ltd. | Verfahren zur Herstellung von Chlorothiazolderivaten |
EP0763531A1 (de) * | 1995-09-14 | 1997-03-19 | Fine Organics Ltd. | Herstellung von substituierten Thiazolen |
EP0780384A2 (de) * | 1995-12-22 | 1997-06-25 | Bayer Ag | Verfahren zur Herstellung von 2-Chlor-5-chlormethylthiazol |
EP0794180A1 (de) * | 1996-02-21 | 1997-09-10 | Kuraray Co., Ltd. | Verfahren zur Herstellung von 2-Chloro-5-Chloromethyl-1,3-Thiazol |
Non-Patent Citations (1)
Title |
---|
GOEBEL T ET AL: "Synthetic approaches towards CGA 293'343: a novel broad-spectrum insecticide", PESTICIDE SCIENCE, vol. 55, no. 3, 1999, pages 355 - 357, XP000960525, ISSN: 0031-613X * |
Also Published As
Publication number | Publication date |
---|---|
DE50002398D1 (de) | 2003-07-03 |
EP1230229B1 (de) | 2003-05-28 |
PT1230229E (pt) | 2003-08-29 |
DK1230229T3 (da) | 2003-09-22 |
EP1230229A1 (de) | 2002-08-14 |
AU7789300A (en) | 2001-05-30 |
ES2194783T3 (es) | 2003-12-01 |
US6812348B1 (en) | 2004-11-02 |
ATE241606T1 (de) | 2003-06-15 |
JP2003523951A (ja) | 2003-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0124009B1 (de) | Verfahren zur Herstellung von Oxiranen | |
EP0463464B1 (de) | Verfahren zur Herstellung von 2-Chlor-5-methyl-pyridin | |
EP0560109B1 (de) | Verfahren zur Herstellung von 1-Fluorcyclopropyl-methyl-keton | |
DE3601927A1 (de) | Alpha, beta-substituierte acroleine, verfahren zu deren herstellung und deren verwendung | |
EP1230229B1 (de) | Verfahren zur herstellung von 2-chlor-5-chlormethyl-1,3-thiazol | |
CH632501A5 (de) | Verfahren zur herstellung von 1-azolyl-3,3-dimethyl-1-phenoxy-butan-2-onen. | |
EP0132733A2 (de) | Neue Fluorpivalsäurefluoride und Verfahren zu ihrer Herstellung | |
DE69802470T2 (de) | Verfahren zur Herstellung von halogenierten o-Hydroxydiphenylverbindungen | |
EP0002480B1 (de) | Verfahren zur Herstellung von 1,2-Oxazolderivaten | |
DE69305828T2 (de) | Verfahren zur Herstellung von 2-Iminothiazolin-Derivaten und Verfahren zur Herstellung ihrer Zwischenprodukte | |
EP0124014A2 (de) | Verfahren zur Herstellung von Oxiranen | |
EP0074121B1 (de) | 2,3,4,5-Tetrahydro-1-benzoxepin-3,5-dion-Derivate und Verfahren zu deren Herstellung | |
EP0157270B1 (de) | Verfahren zur Herstellung von tetrachlorierten Benzo-1,4-dioxenen | |
EP0893441B1 (de) | Verfahren zur Herstellung von Pyridylmethylisothiocyanaten | |
EP0439745A2 (de) | Verfahren zur Herstellung von 2-Chlor-5-methyl-pyridin | |
AT409760B (de) | Verfahren zur herstellung von 2-chlor-5-chlormethyl-1,3-thiazol | |
EP0048372B1 (de) | Verfahren zur Herstellung von Pyrazol | |
EP0290903B1 (de) | Beta-Fluoracyl-beta-halogenvinylalkylether | |
EP0250897B1 (de) | Verfahren zur Herstellung von Hydroxybenzaldoxim-O-ethern | |
DE69018619T2 (de) | Alpha, beta-ungesättigte ketone und ketoximderivat. | |
DE10017882A1 (de) | Verfahren zur Herstellung von 4-Brom-und 4-Chlor-2-nitro-1-trifluormethoxy-benzol | |
DE69408495T2 (de) | Verfahren zur Herstellung von aromatischen Isothiocyanatderivaten | |
EP0000042B1 (de) | Verfahren zur Herstellung von 2,4,5-Trichlorpyrimidin | |
EP0122479A1 (de) | 3-Chlor-1,1-dialkoxyacetone und Verfahren zu ihrer Herstellung | |
DE2460909A1 (de) | Verfahren zur herstellung von alphaoxothiodimethylamiden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AU AZ BA BB BG BR BY BZ CA CN CR CU CZ DM DZ EE GD GE HR HU ID IL IN IS JP KG KP KR KZ LC LK LR LT LV MA MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000967893 Country of ref document: EP Ref document number: 10111011 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2001 538889 Country of ref document: JP Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2000967893 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000967893 Country of ref document: EP |